LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $921,875

Key CONT_AWD_75N91025F00019_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 359 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91025F00019_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91025F00019_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:56:27Z

Content hash 6c4c8fa73bd2f57283cd227e8022df30e896851bb75428a3224d3e9e12e08345

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$921,875	first version	September 11, 2025	September 11, 2025	2026-09-05T00:56:27Z	historical sweep	`6c4c8fa73bd2`

Archived copy

https://web.archive.org/web/20261017162822/https://www.usaspending.gov/award/CONT_AWD_75N91025F00019_7529_75N91019D00024_7529 captured by this system, October 17, 2026

What the amount is made of

One recorded action, so the amount is that single obligation and nothing about it is cumulative. Measured 2026-10-08, when USAspending reported a total obligation of $921,875.

Action date	Modification	Type	Obligated	Description as recorded
September 11, 2025	base	not on file	+$921,875	LEAD OPTIMIZATION OF A LONG NON-CODING RNA (LNCRNA) AS A POTENTIAL LIPID- AND GLUCOSE-LOWERING THERAPEUTIC

Last refreshed November 4, 2026 at 2:31 PM UTC.